IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Greed Is Good who wrote (219)	1/30/1998 10:03:00 AM
From: Harry D. Kramer	of 1510

No one cares about IMNR being short the estimate by 1 cent in the 4th quarter. It's the R&D pipeline that matters and that is what drives the stock price. With all the news in the RA (CYPB, CNTO, IMNX, ...) and AIDS vaccine (new NIAID studies, etc.) area lately, some shareholders obviously got the impression that potential competition for IMNR pipeline products may become a problem over the long-term. Insider selling by J.B.Glavin didn't help, either. Harry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next